Health Care
Commentary
Louisiana Tries Hard, But Federal Obstacles Cause Hepatitis C Plan To Fall Short
A state and a biopharmaceutical company agreed recently on a new way to pay for treating patients with Hepatitis C, the most deadly infectious disease in America. At a time when politicians and drug companies are squabbling over drug prices, the deal between Louisiana and Asegua, a subsidiary of Gilead Sciences, ...
Commentary
Trump’s Drug Importation Policy Is Folly, Just Ask Canadians
The Trump Administration’s Department of Health and Human Services (HHS) has officially proposed legalizing the importation of drugs from Canada (e.g. the Safe Importation Action Plan). Canadians’ reactions provide an important perspective demonstrating why drug importation will harm the U.S. Despite assurances from Prime Minister Justin Trudeau, Canadians are worried ...
Commentary
Americans Support Paying for Miracle Cures
Without pro-market payment reforms, cutting edge medical treatments known as gene therapies run the risk of becoming the dance that no one attends. Gene therapies are not medicines, instead, they are akin to an organ transplant. These procedures typically use re-engineered viruses to repair, replace, or shut off malfunctioning genes ...
Commentary
Foreign drugs import danger
The Trump administration just announced it is taking steps to introduce a “safe importation action” pilot program authorizing states, wholesalers, and pharmacists to import drugs from Canada under one scenario and from other countries under another scenario. There is no specific timeline for implementation of a plan yet. According to the Secretary of ...
Commentary
Judge Delivers A Big Victory For Affordable Health Care
Just over two weeks ago, U.S. District Court Judge Richard Leon upheld a Trump administration rule that expands access to short-term, limited duration health plans. The ruling represents a major victory for those in need of affordable health coverage. But the plaintiffs are appealing the ruling. And many states have already ...
Commentary
Sally Pipes Fox News Op-Ed: Socialized medicine for all is favored by Dem presidential hopefuls – Despite their denials
Health care took center stage when 20 Democratic presidential hopefuls debated in Detroit this week. Only a few candidates pledged to implement “Medicare-for-all.” The rest proposed a variety of plans aimed at achieving universal coverage, which they claimed are more “moderate” alternatives. Don’t believe it. Every Democratic candidate’s plan will ...
Health Care
Watch Sally C. Pipes on C-SPAN discuss Medicare For All
Watch Sally C. Pipes, PRI’s President and CEO, discusses Medicare For ALL at a Heritage Foundation event in Washington D.C. Ms. Pipes remarks begin at the 57 minute-mark. Watch here
Commentary
PRI’s Henry Miller in the LA Times: A smarter way to curb drug prices through imports
A smarter way to curb drug prices through imports By Henry I. Miller, M.S., M.D. and John J. Cohrssen The Trump administration last week announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. It is a goal supported by President Trump, but long ...
Health Care
Watch Sally C. Pipes Discuss Medicare for All with the Heritage Foundation
Sally C. Pipes joins a panel at the Heritage Foundation in Washington D.C. to discuss how the real life costs of Medicare for All will impact Americans.
Health Care
Sally C. Pipes Talks Single-Payer Healthcare with KWIT-FM in Iowa
Sally C. Pipes, PRI’s President and CEO, and Thomas W. Smith Fellow in Health Care Policy, discusses single-payer healthcare plans with NPR-affiliate KWIT-FM in Sioux City. Click to listen here
Louisiana Tries Hard, But Federal Obstacles Cause Hepatitis C Plan To Fall Short
A state and a biopharmaceutical company agreed recently on a new way to pay for treating patients with Hepatitis C, the most deadly infectious disease in America. At a time when politicians and drug companies are squabbling over drug prices, the deal between Louisiana and Asegua, a subsidiary of Gilead Sciences, ...
Trump’s Drug Importation Policy Is Folly, Just Ask Canadians
The Trump Administration’s Department of Health and Human Services (HHS) has officially proposed legalizing the importation of drugs from Canada (e.g. the Safe Importation Action Plan). Canadians’ reactions provide an important perspective demonstrating why drug importation will harm the U.S. Despite assurances from Prime Minister Justin Trudeau, Canadians are worried ...
Americans Support Paying for Miracle Cures
Without pro-market payment reforms, cutting edge medical treatments known as gene therapies run the risk of becoming the dance that no one attends. Gene therapies are not medicines, instead, they are akin to an organ transplant. These procedures typically use re-engineered viruses to repair, replace, or shut off malfunctioning genes ...
Foreign drugs import danger
The Trump administration just announced it is taking steps to introduce a “safe importation action” pilot program authorizing states, wholesalers, and pharmacists to import drugs from Canada under one scenario and from other countries under another scenario. There is no specific timeline for implementation of a plan yet. According to the Secretary of ...
Judge Delivers A Big Victory For Affordable Health Care
Just over two weeks ago, U.S. District Court Judge Richard Leon upheld a Trump administration rule that expands access to short-term, limited duration health plans. The ruling represents a major victory for those in need of affordable health coverage. But the plaintiffs are appealing the ruling. And many states have already ...
Sally Pipes Fox News Op-Ed: Socialized medicine for all is favored by Dem presidential hopefuls – Despite their denials
Health care took center stage when 20 Democratic presidential hopefuls debated in Detroit this week. Only a few candidates pledged to implement “Medicare-for-all.” The rest proposed a variety of plans aimed at achieving universal coverage, which they claimed are more “moderate” alternatives. Don’t believe it. Every Democratic candidate’s plan will ...
Watch Sally C. Pipes on C-SPAN discuss Medicare For All
Watch Sally C. Pipes, PRI’s President and CEO, discusses Medicare For ALL at a Heritage Foundation event in Washington D.C. Ms. Pipes remarks begin at the 57 minute-mark. Watch here
PRI’s Henry Miller in the LA Times: A smarter way to curb drug prices through imports
A smarter way to curb drug prices through imports By Henry I. Miller, M.S., M.D. and John J. Cohrssen The Trump administration last week announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. It is a goal supported by President Trump, but long ...
Watch Sally C. Pipes Discuss Medicare for All with the Heritage Foundation
Sally C. Pipes joins a panel at the Heritage Foundation in Washington D.C. to discuss how the real life costs of Medicare for All will impact Americans.
Sally C. Pipes Talks Single-Payer Healthcare with KWIT-FM in Iowa
Sally C. Pipes, PRI’s President and CEO, and Thomas W. Smith Fellow in Health Care Policy, discusses single-payer healthcare plans with NPR-affiliate KWIT-FM in Sioux City. Click to listen here
